Evidence map›Paper›PMID 30619080›Full record

ArticleFrontiers in endocrinology2018

Low Prevalence of Isolated Growth Hormone Deficiency in Patients After Brain Injury: Results From a Phase II Pilot Study.

Miriam Leonhardt, Anna Kopczak, Barbara Schäpers, Janina Limbrock, Philipp G Sämann, Michael Czisch, Nicole von Steinbuechel, Martina Jordan, Harald J Schneider, Manfred Schneider and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Miriam LeonhardtSchön Klinik Bad Aibling, Bad Aibling, Germany.
Anna KopczakMax Planck Institute of Psychiatry, Munich, Germany.
Barbara SchäpersSchön Klinik Bad Aibling, Bad Aibling, Germany.
Janina LimbrockMax Planck Institute of Psychiatry, Munich, Germany.
Philipp G SämannMax Planck Institute of Psychiatry, Munich, Germany.
Michael CzischMax Planck Institute of Psychiatry, Munich, Germany.
Nicole von SteinbuechelInstitute for Medical Psychology and Medical Sociology, University Medicine Göttingen, Göttingen, Germany.
Martina JordanClinSupport, Erlangen, Germany.
Harald J SchneiderCenter for Endocrinology and Metabolism Nymphenburg, Munich, Germany.
Manfred SchneiderSchön Klinik Bad Aibling, Bad Aibling, Germany.
Caroline SieversMax Planck Institute of Psychiatry, Munich, Germany.
Günter K StallaMax Planck Institute of Psychiatry, Munich, Germany.
Max Planck Institute of Psychiatry · DESchön Klinik Bad Aibling · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growth hormone deficiency (GHD) results in an impaired health-related quality of life (HrQoL) and cognitive impairment in the attention and memory domain. GHD is assumed to be a frequent finding after brain injury due to traumatic brain injury (TBI), aneurysmal subarachnoid hemorrhage (SAH) or ischemic stroke. Hence, we set out to investigate the effects of growth hormone (GH) replacement therapy in patients with isolated GHD after brain injury on HrQoL, cognition, and abdominal fat composition. In total, 1,408 patients with TBI, SAH or ischemic stroke were screened for inclusion. Of those, 54 patients (age 18-65 years) were eligible, and 51 could be tested for GHD with GHRH-

Indexed as

brain injurycognitiondepressiongrowth hormonehealth-related quality of lifeneurorehabilitationvisceral fat

Identifiers

PMID30619080
PMCPMC6305071
OpenAlexW2904994348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.